Related Experiment Video
Updated: Nov 29, 2025

Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets
Published on: September 6, 2019
Pediatric HIV-1 Acquisition and Lifelong Consequences of Infant Infection
Cody S Nelson1, Genevieve G A Fouda1, Sallie R Permar1
1Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.
Insights
Despite advances in antiretroviral therapy, over 170,000 children still acquire HIV annually. Understanding immune factors is crucial for developing targeted therapies to prevent mother-to-child HIV transmission (MTCT).
Area of Science:
- Immunology
- Virology
- Public Health
Background:
- Antiretroviral therapy (ART) has significantly reduced HIV vertical transmission, but implementation challenges persist, leading to over 170,000 pediatric HIV infections annually.
- Mother-to-child transmission (MTCT) of HIV-1 occurs via intrauterine, intrapartum, or postpartum routes, complicated by the diverse maternal-fetal interface.
- Pediatric HIV infection remains a global health challenge, necessitating novel strategies beyond current ART protocols.
Purpose of the Study:
- To investigate the biological mechanisms underlying pediatric HIV infection.
- To identify unique immune factors that confer protection against different modes of HIV MTCT.
- To inform the development of targeted immune interventions for preventing infant HIV acquisition.
Main Methods:
- Analysis of mother-infant human cohorts.
- Utilizing nonhuman primate models for simian immunodeficiency virus (SIV) acquisition studies.
- Investigating the maternal-fetal interface in the context of HIV transmission.
Main Results:
- Observations on the biology of pediatric HIV infection have been made.
- Unique protective immune factors have been identified for distinct MTCT routes.
- The heterogeneity of the maternal-fetal interface presents challenges for immune intervention.
Conclusions:
- Knowledge of protective immune factors is critical for preventing infant HIV acquisition.
- Targeted immune therapies are essential to eradicate the pediatric AIDS epidemic.
- Further research into immune responses at different stages of MTCT is warranted.
Abstract:
Increased availability of antiretroviral therapy to pregnant and breastfeeding women in resource-limited areas has proven remarkably successful at reducing HIV vertical transmission rates over the past several decades. Yet, still more than 170,000 children are infected annually due to failures in therapy implementation, monitoring, and adherence. Mother-to-child transmission (MTCT) of HIV-1 can occur at one of several distinct stages of infant development - intrauterine, intrapartum, and postpartum. The heterogeneity of the maternal-fetal interface at each of these modes of transmission poses a challenge for the implementation of immune interventions to prevent all modes of HIV MTCT. However, using mother-infant human cohorts and nonhuman primate models of infant simian immunodeficiency virus (SIV) acquisition, investigators have made important observation about the biology of pediatric HIV infection and have identified unique protective immune factors for each mode of transmission. Knowledge of immune factors protective against HIV MTCT will be critical to the development of targeted immune therapies to prevent infant HIV acquisition and to bring an end to the pediatric AIDS epidemic.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Retrovirus Life Cycles
Sexually Transmitted Infections
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

